{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:03:55Z","timestamp":1791511435808,"version":"4.3.4"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jcte.2024.100365","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T13:40:31Z","timestamp":1723642831000},"page":"100365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Testosterone deficiency and chronic kidney disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Michael","family":"Zitzmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcte.2024.100365_b0005","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5534\/wjmh.230110","article-title":"Is there a two-way risk between decreased testosterone levels and the progression and prognosis of chronic kidney disease? A cohort study based on the national health and nutrition examination survey database","volume":"42","author":"Pan","year":"2024","journal-title":"World J Mens Health"},{"issue":"5","key":"10.1016\/j.jcte.2024.100365_b0010","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.jcte.2024.100365_b0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.48692","article-title":"Prostate safety events during testosterone replacement therapy in men with hypogonadism: a randomized clinical Trial","volume":"6","author":"Bhasin","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.jcte.2024.100365_b0020","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/clinem\/dgae026","article-title":"Depressive syndromes in men with hypogonadism in the TRAVERSE trial: response to testosterone-replacement therapy","volume":"109","author":"Bhasin","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2024.100365_b0025","doi-asserted-by":"crossref","first-page":"1135530","DOI":"10.3389\/fendo.2023.1135530","article-title":"Role of sex hormones in diabetic nephropathy","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.jcte.2024.100365_b0030","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/ckj\/sfad101","article-title":"Management of traditional risk factors for the development and progression of chronic kidney disease","volume":"16","author":"Lo","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jcte.2024.100365_b0035","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1523-1755.2004.00497.x","article-title":"Testosterone promotes apoptotic damage in human renal tubular cells","volume":"65","author":"Verzola","year":"2004","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.jcte.2024.100365_b0040","doi-asserted-by":"crossref","first-page":"8244","DOI":"10.3390\/ijms24098244","article-title":"Role of sex hormones in prevalent kidney diseases","volume":"24","author":"Conte","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jcte.2024.100365_b0045","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamainternmed.2016.9539","article-title":"Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone: A controlled clinical trial","volume":"177","author":"Snyder","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.jcte.2024.100365_b0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2017-00234","article-title":"Lessons from the testosterone trials","volume":"39","author":"Snyder","year":"2018","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.jcte.2024.100365_b0055","article-title":"Testosterone: a metabolic hormone in health and disease","volume":"217","author":"Kelly","year":"2013","journal-title":"J Endocrinol"},{"issue":"1","key":"10.1016\/j.jcte.2024.100365_b0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","article-title":"Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial","volume":"9","author":"Wittert","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.jcte.2024.100365_b0065","doi-asserted-by":"crossref","DOI":"10.1677\/joe.0.1780373","article-title":"Testosterone as a protective factor against atherosclerosis\u2014immunomodulation and influence upon plaque development and stability","volume":"217","author":"Malkin","year":"2010","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.jcte.2024.100365_b0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jcte.2024.100365_b0075","doi-asserted-by":"crossref","DOI":"10.1097\/XCE.0000000000000305","article-title":"The role of sex hormones in aldosterone biosynthesis and their potential impact on its mineralocorticoid receptor","volume":"13","author":"Vecchiola","year":"2024","journal-title":"Cardiovasc Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jcte.2024.100365_b0080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/13685538.2022.2063830","article-title":"The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men","volume":"25","author":"Zitzmann","year":"2022","journal-title":"Aging Male"},{"issue":"10","key":"10.1016\/j.jcte.2024.100365_b0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.40030","article-title":"Efficacy of testosterone replacement therapy in correcting anemia in men with hypogonadism: a randomized clinical trial","volume":"6","author":"Pencina","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jcte.2024.100365_b0090","article-title":"Testosterone increases: sodium reabsorption, blood pressure, and renal pathology in female spontaneously hypertensive rats on a high sodium diet","volume":"817835","author":"Liu","year":"2011","journal-title":"Adv Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.jcte.2024.100365_b0095","doi-asserted-by":"crossref","first-page":"768","DOI":"10.7326\/M23-2781","article-title":"Associations of testosterone and related hormones with all-cause and cardiovascular mortality and incident cardiovascular disease in men: individual participant data meta-analyses","volume":"177","author":"Yeap","year":"2024","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jcte.2024.100365_b0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13293-020-00324-5","article-title":"Hypogonadal hypertension in male Sprague-Dawley rats is renin-angiotensin system-dependent: role of endogenous androgens","volume":"11","author":"Hanson","year":"2020","journal-title":"Biol Sex Differ"},{"issue":"5","key":"10.1016\/j.jcte.2024.100365_b0105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/andr.12770","article-title":"European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology","volume":"8","author":"Corona","year":"2020","journal-title":"Andrology"},{"issue":"4S","key":"10.1016\/j.jcte.2024.100365_b0110","article-title":"Kidney disease: improving global outcomes (KDIGO). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jcte.2024.100365_b0115","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Executive summary of the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: known knowns and known unknowns","volume":"105","author":"Levin","year":"2024","journal-title":"Kidney Int"},{"issue":"9811","key":"10.1016\/j.jcte.2024.100365_b0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jcte.2024.100365_b0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","article-title":"Update on lupus nephritis: core curriculum 2020","volume":"76","author":"Parikh","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.jcte.2024.100365_b0130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/MNH.0000000000000969","article-title":"New guidelines and therapeutic updates for the management of lupus nephritis","volume":"33","author":"Desai","year":"2024","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"19","key":"10.1016\/j.jcte.2024.100365_b0135","doi-asserted-by":"crossref","first-page":"14526","DOI":"10.3390\/ijms241914526","article-title":"Lupus nephritis risk factors and biomarkers: an update","volume":"24","author":"Renaudineau","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcte.2024.100365_b0140","doi-asserted-by":"crossref","first-page":"1360026","DOI":"10.3389\/fmed.2024.1360026","article-title":"Rheumatoid arthritis and the risk of chronic kidney diseases: a Mendelian randomization study","volume":"11","author":"Jiang","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.jcte.2024.100365_b0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/jcm13010201","article-title":"Incretin therapies for patients with type 2 diabetes and chronic kidney disease","volume":"13","author":"Alicic","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcte.2024.100365_b0150","article-title":"The impact of long-term Testosterone Therapy (TTh) in renal function (RF) among hypogonadal men: An observational cohort study","volume":"69","author":"Alwani","year":"2021","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.jcte.2024.100365_b0155","article-title":"Tubulointerstitial nephritis","author":"Bhandari","year":"2024","journal-title":"StatPearls [Internet]"},{"issue":"1","key":"10.1016\/j.jcte.2024.100365_b0160","doi-asserted-by":"crossref","first-page":"23639","DOI":"10.1038\/s41598-021-03033-0","article-title":"Impact of acute kidney injury on long-term adverse outcomes in obstructive uropathy","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.jcte.2024.100365_b0165","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajh.2010.174","article-title":"Renovascular hypertension and ischemic nephropathy","volume":"23","author":"Textor","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jcte.2024.100365_b0170","article-title":"Improving outcomes in atherosclerotic renovascular disease: importance of clinical presentation and multi-disciplinary review","author":"de Bhailis","year":"2024","journal-title":"J Nephrol"},{"key":"10.1016\/j.jcte.2024.100365_b0175","article-title":"Risk factors for chronic kidney disease: an update","volume":"2013","author":"Kazancio\u011flu","year":"2011","journal-title":"Kidney Int Suppl"},{"issue":"1\u20132","key":"10.1016\/j.jcte.2024.100365_b0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2014.01.014","article-title":"Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit","volume":"384","author":"Vignozzi","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"10.1016\/j.jcte.2024.100365_b0185","first-page":"1251","article-title":"Association between testosterone levels and clinical outcomes in hemodialysis patients in the EVOLVE trial","volume":"34","author":"Nilsson","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.jcte.2024.100365_b0190","first-page":"293","article-title":"Thyroid, gonadal, and adrenal dysfunction in kidney transplant recipients: a comprehensive review","volume":"44","author":"Bilha","year":"2023","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.jcte.2024.100365_b0195","first-page":"518","article-title":"Sex hormone-binding globulin and insulin resistance in men undergoing chronic hemodialysis: a cross-sectional study","volume":"60","author":"Nikolaou","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jcte.2024.100365_b0200","article-title":"Real world data in health technology assessments in kidney transplants in Germany: use of routinely collected data to address epidemiologic questions in kidney transplants in the AMNOG process in Germany","volume":"16","author":"Herrmann","year":"2018","journal-title":"Ger Med Sci"},{"issue":"24","key":"10.1016\/j.jcte.2024.100365_b0205","first-page":"00275","article-title":"Comparing the prognostic performance of iBOX and biopsy-proven acute rejection for long-term kidney graft survival","volume":"S1600\u20136135","author":"Klein","year":"2024","journal-title":"Am J Transplant"},{"issue":"16","key":"10.1016\/j.jcte.2024.100365_b0210","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.3390\/nu14163438","article-title":"Testosterone deficiency as one of the major endocrine disorders in chronic kidney disease","volume":"14","author":"Romejko","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jcte.2024.100365_b0215","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.semnephrol.2021.03.006","article-title":"Testosterone disorders and male hypogonadism in kidney disease","volume":"41","author":"Garibotto","year":"2021","journal-title":"Semin Nephrol"},{"issue":"7","key":"10.1016\/j.jcte.2024.100365_b0220","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajh.2011.71","article-title":"Postmenopausal hypertension","volume":"24","author":"Yanes","year":"2011","journal-title":"Am J Hypertens"},{"issue":"11","key":"10.1016\/j.jcte.2024.100365_b0225","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/dom.14122","article-title":"Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study","volume":"22","author":"Haider","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.jcte.2024.100365_b0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000119417","article-title":"Testosterone and blood pressure regulation","volume":"31","author":"Kienitz","year":"2008","journal-title":"Kidney Blood Press Res"},{"issue":"6","key":"10.1016\/j.jcte.2024.100365_b0235","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1472-8206.2010.00854.x","article-title":"Gender and the renin-angiotensin-aldosterone system","volume":"24","author":"Komukai","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.jcte.2024.100365_b0240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1515\/hmbci-2012-0023","article-title":"Effects of short-term testosterone administration on variables of the metabolic syndrome, in particular aldosterone","volume":"12","author":"Goncharov","year":"2012","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"2","key":"10.1016\/j.jcte.2024.100365_b0245","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1124\/mol.106.031112","article-title":"The synthetic androgen methyltrienolone (r1881) acts as a potent antagonist of the mineralocorticoid receptor","volume":"71","author":"Takeda","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.jcte.2024.100365_b0250","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/andr.12728","article-title":"Low serum testosterone levels and the incidence of chronic kidney disease among male adults: A prospective population-based study","volume":"8","author":"Amiri","year":"2020","journal-title":"Andrology"},{"issue":"7","key":"10.1016\/j.jcte.2024.100365_b0255","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2215\/CJN.10681210","article-title":"Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease","volume":"6","author":"Yilmaz","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.jcte.2024.100365_b0260","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ndt\/gfr288","article-title":"Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease","volume":"27","author":"Carrero","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.jcte.2024.100365_b0265","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.ekir.2023.06.005","article-title":"Prospective study of associations between testosterone, mortality, and health outcomes among adults undergoing hemodialysis","volume":"8","author":"Lau","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"7","key":"10.1016\/j.jcte.2024.100365_b0270","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2337\/dc10-2339","article-title":"Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes","volume":"34","author":"Wang","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2024.100365_b0275","first-page":"116","article-title":"The relationship between testosterone and molecular markers of inflammation in older men","volume":"28","author":"Maggio","year":"2005","journal-title":"J Endocrinol Investig"},{"issue":"12","key":"10.1016\/j.jcte.2024.100365_b0280","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrendo.2009.212","article-title":"Testosterone deficiency, insulin resistance and the metabolic syndrome","volume":"5","author":"Zitzmann","year":"2009","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.jcte.2024.100365_b0285","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.jrn.2017.01.023","article-title":"Visceral adipose tissue and leptin hyperproduction are associated with hypogonadism in men with chronic kidney disease","volume":"27","author":"Cobo","year":"2017","journal-title":"J Ren Nutr"},{"issue":"1","key":"10.1016\/j.jcte.2024.100365_b0290","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.nefro.2016.04.009","article-title":"Hypogonadism associated with muscle atrophy, physical inactivity and ESA hyporesponsiveness in men undergoing haemodialysis","volume":"37","author":"Cobo","year":"2017","journal-title":"Nefrologia"},{"issue":"3","key":"10.1016\/j.jcte.2024.100365_b0295","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/ndt\/17.3.368","article-title":"Sexual hormone abnormalities in male patients with renal failure","volume":"17","author":"Schmidt","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.jcte.2024.100365_b0300","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","article-title":"Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study","volume":"87","author":"Feldman","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jcte.2024.100365_b0305","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/089686089401400409","article-title":"Anabolic steroids and malnutrition in chronic renal failure","volume":"14","author":"Soliman","year":"1994","journal-title":"Perit Dial Int"},{"issue":"1","key":"10.1016\/j.jcte.2024.100365_b0310","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1525-139x.2000.00011.x","article-title":"Use of androgens in patients with renal failure","volume":"13","author":"Johnson","year":"2000","journal-title":"Semin Dial"},{"issue":"11","key":"10.1016\/j.jcte.2024.100365_b0315","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1210\/jcem.86.11.7983","article-title":"Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases","volume":"86","author":"Basaria","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jcte.2024.100365_b0320","first-page":"173","article-title":"Iron and androgens in the treatment of anemia in periodic hemodialysis","volume":"121","author":"Valderr\u00e1bano","year":"1971","journal-title":"Rev Clin Esp"},{"issue":"5768","key":"10.1016\/j.jcte.2024.100365_b0325","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/bmj.3.5768.212","article-title":"Testosterone therapy for anaemia in maintenance dialysis","volume":"3","author":"Shaldon","year":"1971","journal-title":"Br Med J"},{"issue":"52","key":"10.1016\/j.jcte.2024.100365_b0330","first-page":"1938","article-title":"Testosterone treatment of renal anemia. Evaluation of success by means of morphometric bone marrow and erythrocyte volume determinations","volume":"104","author":"Keyssner","year":"1974","journal-title":"Schweiz Med Wochenschr"},{"issue":"1","key":"10.1016\/j.jcte.2024.100365_b0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000180761","article-title":"Androgens in the anaemia of chronic renal failure","volume":"18","author":"von Hartitzsch","year":"1977","journal-title":"Nephron"},{"issue":"1","key":"10.1016\/j.jcte.2024.100365_b0340","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2337\/dc15-1518","article-title":"Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes","volume":"39","author":"Dhindsa","year":"2016","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jcte.2024.100365_b0345","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgab149","article-title":"Effect of testosterone treatment on bone microarchitecture and bone mineral density in men: A 2-year RCT","volume":"106","author":"Ng Tang Fui","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jcte.2024.100365_b0350","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-22-0319","article-title":"Androgen therapy does not prevent bone loss and arterial calcifications in male rats with chronic kidney disease","volume":"257","author":"David","year":"2023","journal-title":"J Endocrinol"},{"issue":"4","key":"10.1016\/j.jcte.2024.100365_b0355","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/13685538.2018.1506918","article-title":"Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial","volume":"22","author":"Khripun","year":"2019","journal-title":"Aging Male"},{"issue":"6","key":"10.1016\/j.jcte.2024.100365_b0360","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-13-0321","article-title":"Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes","volume":"169","author":"Muraleedharan","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.jcte.2024.100365_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100796","article-title":"Cystatin C- and creatinine-based estimated GFR differences: prevalence and predictors in the UK biobank","volume":"6","author":"Chen","year":"2024","journal-title":"Kidney Med"},{"issue":"1","key":"10.1016\/j.jcte.2024.100365_b0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226509","article-title":"Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study","volume":"15","author":"Willey","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jcte.2024.100365_b0375","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12291-023-01125-4","article-title":"A comparative study on the efficacy between cystatin c and creatinine-based equations for early detection of renal damage in patients of eastern India","volume":"39","author":"Dastidar","year":"2024","journal-title":"Indian J Clin Biochem"},{"issue":"35","key":"10.1016\/j.jcte.2024.100365_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/HYHN1078","article-title":"Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C study","volume":"28","author":"Lamb","year":"2024","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.jcte.2024.100365_b0385","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jcte.2024.100365_b0390","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2217\/pgs.09.58","article-title":"Pharmacogenetics of testosterone replacement therapy","volume":"10","author":"Zitzmann","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.jcte.2024.100365_b0395","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-13-0703","article-title":"The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study","volume":"170","author":"Stanworth","year":"2013","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221462372400036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221462372400036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T22:52:45Z","timestamp":1726786365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221462372400036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":79,"alternative-id":["S221462372400036X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2024.100365","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone deficiency and chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2024.100365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100365"}}